Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 23 Oct 2026 for Quest Diagnostics INC, €6,933.
Filing timeline
BuySaleKarthik Kuppusamy
Insider track record
Disclosed buys
0
Disclosed sells
8
Signal history
Karthik Kuppusamy: trading record in brief
Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics Inc, has filed 50 disclosures since February 3, 2023, including 8 sales worth EUR 3,163,856 in total with a median of EUR 363,523. There is no purchase. The largest is dated July 30, 2025 (EUR 765,133), the same day as another of EUR 445,986; in between, EUR 463,625 on March 4, 2026.
The record holds 30 share grants, 10 filings of another kind and 2 option exercises. By year: 10 filings in 2023, 14 in 2024, 17 in 2025 and 9 in 2026. Ten filings, one of them a sale, fall in the last twelve months.
Among Quest Diagnostics colleagues, Patrick Plewman totals 4 trades near Kuppusamy's (within 30 days), Catherine T. Doherty and Michael E. Prevoznik 3, J. E. Davis 2, Michael J. Deppe 1, all in the same direction. Filings are published a median of 2 days after the trade.
Companies and markets linked to Karthik Kuppusamy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations51 total
33 shares@ US$235.944Common StockSEC:0001022079-26-000113:0
37 shares@ US$206.8070.0000% mcap0.1% of flowCommon StockSEC:0001022079-26-000086:0
39 shares@ US$194.6990.0000% mcap0.1% of flowCommon StockSEC:0001022079-26-000045:0
2,628 shares@ US$204.865.4% of flowCommon StockSEC:0001022079-26-000025:1
6,200 shares@ US$204.8622.4% of flowCommon StockSEC:0001022079-26-000025:0
205 shares@ US$204.860.7% of flowCommon StockSEC:0001022079-26-000019:0
2,135 shares0Common StockSEC:0001955217-26-000002:2
259 shares@ US$206.990.5% of flowCommon StockSEC:0001955217-26-000002:1
16 shares@ US$183.520.0% of flowCommon StockSEC:0001955217-26-000002:3
252 shares@ US$210.010.0002% mcap0.9% of flowCommon StockSEC:0001955217-26-000002:0
15 shares@ US$189.0760.0000% mcap0.0% of flowCommon StockSEC:0001022079-25-000229:0
123 shares@ US$175.910.4% of flowCommon StockSEC:0001955217-25-000005:0
3,045 shares@ US$167.405.1% of flowCommon StockSEC:0001022079-25-000195:1
5,224 shares@ US$112.175.9% of flowCommon StockSEC:0001022079-25-000195:2
5,224 shares@ US$167.408.8% of flowCommon StockSEC:0001022079-25-000195:3
2,210 shares@ US$170.003.8% of flowCommon StockSEC:0001022079-25-000195:4
3,045 shares@ US$86.634.7% of flowCommon StockSEC:0001022079-25-000195:0
27 shares@ US$167.4980.0000% mcap0.1% of flowCommon StockSEC:0001022079-25-000187:0
27 shares@ US$164.4220.1% of flowCommon StockSEC:0001022079-25-000129:0
2,555 shares@ US$170.008.1% of flowCommon StockSEC:0001022079-25-000107:0
4,434 shares@ US$173.748.5% of flowCommon StockSEC:0001022079-25-000089:1
1,879 shares@ US$173.743.6% of flowCommon StockSEC:0001022079-25-000089:2
992 shares@ US$173.743.4% of flowCommon StockSEC:0001022079-25-000089:0
233 shares@ US$171.750.8% of flowCommon StockSEC:0001022079-25-000072:0
287 shares@ US$169.711.0% of flowCommon StockSEC:0001022079-25-000054:0
25 of 51 declarations
